Tumours of the 3rd recurrence (2.63 NE IQR 1.35-3.57) showed a significant difference in their PD-L1 expression (64.3% less expression of PD-L1 in comparison to de-novo tumours, p=0.0046). Here, CD274 is linked to neoplasm.